Seaward Management Limited Partnership Sells 2,826 Shares of Colgate-Palmolive (CL)

Seaward Management Limited Partnership reduced its holdings in shares of Colgate-Palmolive (NYSE:CL) by 1.6% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 175,841 shares of the company’s stock after selling 2,826 shares during the quarter. Seaward Management Limited Partnership’s holdings in Colgate-Palmolive were worth $12,810,000 at the end of the most recent quarter.

Several other hedge funds have also made changes to their positions in CL. Vanguard Group Inc. lifted its stake in Colgate-Palmolive by 2.4% in the 2nd quarter. Vanguard Group Inc. now owns 67,875,384 shares of the company’s stock worth $5,031,602,000 after purchasing an additional 1,621,392 shares in the last quarter. Renaissance Technologies LLC lifted its stake in Colgate-Palmolive by 42.4% in the 2nd quarter. Renaissance Technologies LLC now owns 9,753,400 shares of the company’s stock worth $723,020,000 after purchasing an additional 2,903,800 shares in the last quarter. Arrowstreet Capital Limited Partnership lifted its stake in Colgate-Palmolive by 25.3% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 6,854,323 shares of the company’s stock worth $508,111,000 after purchasing an additional 1,385,946 shares in the last quarter. First Eagle Investment Management LLC lifted its stake in Colgate-Palmolive by 35.8% in the 3rd quarter. First Eagle Investment Management LLC now owns 6,641,548 shares of the company’s stock worth $483,837,000 after purchasing an additional 1,750,417 shares in the last quarter. Finally, TIAA CREF Investment Management LLC lifted its stake in Colgate-Palmolive by 3.7% in the 2nd quarter. TIAA CREF Investment Management LLC now owns 4,725,042 shares of the company’s stock worth $350,267,000 after purchasing an additional 170,053 shares in the last quarter. Institutional investors own 72.83% of the company’s stock.

Colgate-Palmolive (NYSE CL) opened at $75.33 on Friday. The company has a current ratio of 1.23, a quick ratio of 0.92 and a debt-to-equity ratio of 24.42. Colgate-Palmolive has a twelve month low of $63.43 and a twelve month high of $77.27. The company has a market cap of $65,726.17, a price-to-earnings ratio of 29.09, a P/E/G ratio of 3.19 and a beta of 0.80.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, October 27th. The company reported $0.73 EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.73. Colgate-Palmolive had a net margin of 15.10% and a return on equity of 2,782.56%. The company had revenue of $3.97 billion for the quarter, compared to analyst estimates of $3.94 billion. During the same quarter last year, the firm earned $0.73 EPS. The firm’s quarterly revenue was up 2.8% compared to the same quarter last year. research analysts forecast that Colgate-Palmolive will post 2.88 earnings per share for the current year.

In related news, insider Victoria L. Dolan sold 9,000 shares of the stock in a transaction on Tuesday, November 14th. The shares were sold at an average price of $73.41, for a total transaction of $660,690.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Stephen I. Sadove sold 20,780 shares of the stock in a transaction on Monday, November 6th. The shares were sold at an average price of $70.52, for a total transaction of $1,465,405.60. Following the transaction, the director now directly owns 36,268 shares in the company, valued at approximately $2,557,619.36. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 181,048 shares of company stock worth $13,168,995. 1.02% of the stock is owned by insiders.

CL has been the topic of several recent analyst reports. Zacks Investment Research cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Tuesday, September 26th. Jefferies Group reiterated a “hold” rating and issued a $79.00 target price on shares of Colgate-Palmolive in a research note on Thursday, September 28th. Morgan Stanley lowered their target price on shares of Colgate-Palmolive from $84.00 to $83.00 and set an “overweight” rating on the stock in a research note on Tuesday, October 31st. KeyCorp reiterated a “hold” rating on shares of Colgate-Palmolive in a research note on Monday, October 16th. Finally, Macquarie initiated coverage on shares of Colgate-Palmolive in a research report on Thursday, September 14th. They set a “neutral” rating and a $76.00 price objective on the stock. Three research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and five have issued a buy rating to the company. Colgate-Palmolive currently has a consensus rating of “Hold” and a consensus price target of $76.33.

ILLEGAL ACTIVITY NOTICE: This story was first reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are reading this story on another site, it was copied illegally and reposted in violation of United States and international copyright & trademark law. The original version of this story can be viewed at https://www.chaffeybreeze.com/2018/01/05/seaward-management-limited-partnership-sells-2826-shares-of-colgate-palmolive-cl.html.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply